|
|
||||||||
Department of Physiological Science, University of California, Los Angeles, California 90095-1527
| |
ABSTRACT |
|---|
|
|
|---|
This study investigated the effect of long-term high-fat sucrose (HFS) or low-fat complex-carbohydrate (LFCC) diet consumption on leptin, insulin, fat cell size, energy intake, and markers of activity to ascertain the role that leptin plays in long-term energy balance in a model of diet-induced obesity. Female Fischer 344 rats were fed either a HFS or LFCC diet ad libitum for a period of 20 mo. Measurements of leptin concentration, insulin concentration, and adipocyte size were performed at 2 wk, 2 mo, 6 mo, and 20 mo. Body weight and energy intake were measured weekly for calculation of feed efficiency. Body temperature and activity levels were assessed over a 5-day period after 12 mo of the dietary intervention. Plasma leptin and insulin concentrations were significantly elevated within 2 wk of HFS diet consumption and remained elevated throughout the course of the study. After 2 mo, the adipocytes of the HFS group were significantly larger and continued to increase in size throughout the course of the study. A significant correlation was noted between leptin and adipocyte cell size (r = 0.96, P < 0.01). However, despite elevated leptin, energy intake was similar, and the HFS group weighed significantly more than the LFCC group, as a result of a higher feed efficiency. There were no significant differences in body temperature or activity levels between the groups. These results demonstrate that a HFS diet causes hyperleptinemia and hyperinsulinemia before adipocyte size is increased and suggests that leptin resistance may be present or, alternatively, that leptin does not to play a major role in the long-term regulation of energy intake or activity levels in this model.
insulin; body temperature; adipocyte; metabolism
| |
INTRODUCTION |
|---|
|
|
|---|
LEPTIN, a 16-kDa protein, has been reported to regulate body weight, food intake, energy expenditure, insulin action, and skeletal muscle free fatty acid oxidation. In the ob/ob mouse, which is leptin deficient, hyperphagic, insulin resistant, and obese, recombinant leptin therapy induces a rapid reduction in food intake and obesity, normalizes body temperature, and ameliorates insulin resistance (38). Leptin-induced decreases in serum glucose, insulin, and blood lipids occur before changes in body mass (38).
Conversely, in humans, rarely does a mutation in the leptin gene or the leptin-receptor gene occur (34), and leptin administration results in modest weight loss in obese humans (20). The majority of human obesity results from gene-environment interactions, where dietary factors (i.e., fat and refined carbohydrate) and physical inactivity have long been evidenced to be contributing factors. For example, cross-sectional studies have reported an association between dietary fat and adiposity (3, 23, 32). Many models of diet-induced obesity have demonstrated that animals fed a diet high in fat and/or refined sugar become obese in the absence of excess energy intake (5, 36). It is possible that there may be an alteration in energy expenditure (i.e., decreased thermogenesis or decreased activity levels) that may contribute, in part, to the development of obesity noted in animals fed a high-fat, refined-sugar diet.
Leptin appears to be regulated in humans and animals by short-term alterations in energy intake, because leptin declines with fasting and increases with acute overfeeding (1, 7, 26). The role of leptin in the long-term regulation of body fat via modulation in energy intake and energy expenditure in normal rodents and humans remains unknown. The following experiment was undertaken to examine the long-term effects of diet on leptin, fat cell size, energy intake, and activity in female Fischer 344 rats raised on either a low-fat complex-carbohydrate (LFCC) or a high-fat sucrose (HFS) diet for 20 mo.
| |
METHODS |
|---|
|
|
|---|
Animals and diet. All protocols were conducted in accordance with and approved by the University of California, Los Angeles, Animal Research Committee. Inbred female Fischer 344 rats were obtained from Harlan Sprague Dawley (San Diego, CA) at 2 mo of age, and after a 1-wk period during which the animals were fed standard rat chow, the rats were randomly assigned to either the LFCC or HFS diet (at 9 wk of age) and were housed four per cage with a 12-h light cycle starting at 0700 at 75-76°F. Our laboratory used this rat model in previous studies (4, 40). The diets were provided ad libitum with large bowls placed in the cages to ensure that all animals had access to the food. The diets were prepared in powder form by Purina Test Diets (Richmond, IN) and contained a standard vitamin and mineral mix and all essential nutrients. The LFCC diet (Purina 5001) is low in saturated fat and contains mostly complex carbohydrate (starch), whereas the HFS diet is high in saturated and monounsaturated fat (primarily from lard plus a small amount of corn oil) and high in refined sugar (sucrose) as previously published (40). Both groups were studied at various time points for up to 20 mo of dietary intervention. The rats were weighed weekly, and food intake was measured daily (5 days/wk) in both groups for calculation of energy intake and feed efficiency (FE).
Adipocyte morphology. Fat cell size was determined as previously described (5). Briefly, omental fat samples were removed, rinsed in 0.85% NaCl, and placed in 10% phosphate-buffered formalin. The samples were then dehydrated, filtered, and embedded in paraffin according to the method of Sheehan and Hrapchak (44). Sections were then sliced at a thickness of 4 µm at three different depths, at least 200 µm apart, within the same embedded tissue sample. The samples were then affixed to slides, after which video prints were taken with a Codonics VP-3500 video printer attached to a Perspective Systems image-analysis system connected to an Olympus BH2 microscope. By using the video images, the number of adipocytes within a given area was counted, and the number obtained was used to calculate mean cell number and mean cell volume according to calculations described by Lemonnier (27) and Ashwell et al. (2).
Blood chemistries.
The rats were fasted overnight to eliminate any confounding effects of
the last meal and were anesthetized with 10% chloral hydrate (250 mg/kg ip; University of California, Los Angeles Pharmacy), and blood
was drawn via cardiac puncture. Blood samples were immediately centrifuged, and the plasma was separated and frozen at
70°C. Insulin concentration was quantified by using a double-antibody RIA kit
obtained from Ventrex Laboratories (Portland, ME). Frozen plasma
samples were sent to Linco Research (St. Charles, MO) for quantification of plasma leptin concentration also by using a double-antibody RIA.
Body temperature and activity. Six animals from both groups were analyzed for body temperature and motor activity after 12 mo on their respective diets. With battery-operated, precalibrated biotelmetric transmitters (model VM-FH, Mini Mitter, Sunriver, OR) implanted in the peritoneal cavity, body temperature and motor activity were measured. Transmitter implantation was conducted under halothane anesthesia. After the operation, rats were housed individually and were allowed to recover for 1 wk before measurements were started. The animals were maintained on their respective diets during the recovery period and for 5 additional days of data collection. Output was monitored by a receiver board (model RA-1010) placed under each animals cage and fed into a peripheral processor (BCM100) connected to a personal computer as previously described (52). Body temperature was detected by a sensor imbedded in the transmitter and was recorded at 10-min intervals. Activity was measured by detecting changes in signal that occurred as the animals moved about the cages.
Statistical analysis. Data from the experiments were analyzed by using a Student's t-test or an ANOVA with GraphPad Prism (GraphPad Software, San Diego, CA). When significant F values were found, post hoc analyses were performed by using a Newman-Keuls multiple-comparison test. Differences were considered statistically significant at P < 0.05. Values are reported as means ± SE with 6-8 rats per group for each study, except the body weight, food intake, and energy intake studies, which contained 16 rats per group.
| |
RESULTS |
|---|
|
|
|---|
Plasma leptin, adipocyte size, and plasma insulin.
Leptin concentrations were significantly elevated in the HFS compared
with the LFCC group after 2 wk on the diets (Fig.
1). Leptin levels continued to rise in
the HFS group over the remainder of the study and were significantly
elevated at all time points compared with the LFCC group. Leptin,
although increased slightly with time, was not significantly different
among the LFCC animals, whereas in the HFS group the leptin
concentration at 20 mo was significantly higher compared with the other
time points (P < 0.05).
|
|
Body weight, FE, and energy intake.
Figure 3 shows the average weekly body
weights, food intake (g/day), and energy intake (kJ/day) in the two
groups for 85 wk. Weight gain for the two groups paralleled each other
until week 21, after which the HFS group began to gain
weight at an increased rate compared with the LFCC group, in which
weight gain slowed (Fig. 3). The difference in body weights was not
statistically significant until week 25 (LFCC vs.
HFS: 188 ± 1.4 vs. 214 ± 3.4 g;
P < 0.01), and the difference remained significant
throughout the remainder of the study (final weights: 253.8 ± 6.0 vs. 367.2 ± 9.3 g; P < 0.01).
|
Body temperature and activity levels.
Figure 4 illustrates that, when measured
at 12 mo, there was no significant difference in body temperature
between the HFS and LFCC groups at any time during the day or when
averaged over the entire day. However, the temperature in both groups
was higher during the night compared with the day because rats, being
nocturnal animals, consume most of their food when the lights first go
out. The increased activity levels seen in both groups at night, as demonstrated in Fig. 5, may help explain
the temperature increases. Although the nighttime activity levels were
higher than daytime activity levels, there were no significant
differences seen between the HFS and LFCC groups. The body temperature
and activity counts are presented in Figures 4 and 5 as an average
temperature and total activity per day, respectively, over 5 days.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Obesity is a condition that has reached epidemic levels in recent
years. Flegal et al. (16) estimated that between 1960 and
1994 the proportion of adults in the United States with a body mass
index between 30 and 34.9 kg/m2 rose by 66%. In addition,
it is apparent that the rate of rise in obesity is accelerating, as
Mokdad et al. (33) reported that the proportion of adults
in the United States with a body mass index
30 kg/m2 has
increased nearly 50% from 1991 to 1998.
Leptin has been documented to regulate food intake, body temperature, energy expenditure (38), insulin action (6), and blood pressure (49), and thus it might play a role in the metabolic syndrome. Normal animals and humans exhibit leptin expression and secretion that correlate with body fat mass (11, 31) and with adipocyte size in both lean and obese mice (21). The present study is the first prolonged, longitudinal study to document changes in insulin, leptin, food intake, fat cell size, and markers of energy expenditure simultaneously over a 20-mo period with use of an ad libitum protocol of diet-induced obesity. The results of the present study confirm that prolonged consumption of a HFS diet leads to excessive weight gain and adipocyte hypertrophy compared with a LFCC diet. Leptin was highly correlated with fat cell size but was unrelated to food intake or to energy intake and activity levels, as estimated by body temperature and cage movement.
Studies with the ob/ob and db/db mice have clearly established that leptin regulates food and energy intake in genetic models of obesity. In the present study with normal rats, the volume of food consumed by the HFS animals was consistently less than the volume consumed by the LFCC animals (Fig. 3). However, energy intake was similar for the two groups because of the different energy densities of the two diets. Other studies have documented a similar pattern of food consumption in high-fat-fed animals compared with low-fat-fed animals (36). Li et al. (28) demonstrated in male Fischer 344 rats that food intake was constant over 30 mo in animals fed a standard LFCC chow diet. In addition, it has been reported that short-term leptin administration to lean animals causes a reduction of food intake (9). In the present study, leptin was significantly elevated after 2 wk on the HFS diet and continued to rise with long-term consumption of the HFS diet. However, the increase in leptin was unrelated to food intake and suggests the possibility of leptin resistance in the HFS rats. In support of the leptin resistance theory, Van Heek et al. (48) found that resistance to leptin treatment developed in diet-induced obese mice after 16 days of leptin treatment in high-fat-fed (45% fat cal) animals, whereas animals maintained on a low-fat (10% fat cal) diet retained their sensitivity to exogenous leptin administration. Other data suggests that insulin and dietary fat may induce leptin resistance (29). In the study by Lin et al. (29), the authors demonstrated that the hypophagic effect of leptin in low-fat-fed animals was preserved when the animals were naively fed a high-fat diet but not when high-fat-fed animals were fed a low-fat diet. The authors suggested that a signal related to the low-fat, high-carbohydrate diet was needed for the leptin response, rather than an inhibitory response to dietary fat. Additional studies have shown that diets high in dietary fat can increase plasma leptin in as little as 2 days (30); however, insulin alters adipocyte production of leptin (12, 25), and thus changes in plasma leptin may not accurately reflect the presence of leptin resistance and may be secondary to changes in insulin. For instance, Steinberg and Dyck (45) demonstrated that diet-induced peripheral leptin resistance, as measured by leptin's ability to induce skeletal muscle free fatty acid oxidation, occurs in the absence of changes in plasma leptin.
Another possibility is that, in the long-term, leptin does not regulate food intake per se but rather that it regulates a lack of food intake. In this proposed model, weight loss is the signal that causes a cascade of events beginning with decreased leptin, a drive for increased food intake via hypothalamic mechanisms, and decreased energy expenditure to favor a return to normal body weight. When sufficient energy stores or energy intake has occurred, the metabolic and endocrine alterations are returned to normal. However, further elevation of leptin above a threshold for defense against starvation has no effect on systems of energy homeostasis unless supraphysiological levels of leptin are achieved (41). The relative ineffectiveness in humans of long-term leptin administration for weight control supports this contention (20).
There is evidence that leptin is involved in the regulation of energy expenditure in genetic models of obesity. Leptin administration has been shown to increase energy expenditure and induce weight loss in ob/ob mice by increasing oxygen consumption, body temperature, and locomotor activity (38). However, in rodent models without genetically induced obesity, rather than increasing energy expenditure above basal levels, leptin appears to act primarily to prevent the decline in metabolic rate associated with periods of decreased energy intake (19). This is supported by the present data that demonstrated no difference in body temperature or motor activity between the LFCC and HFS groups despite significant hyperleptinemia in the HFS group. In humans, Wisse et al. (51) reported a positive correlation between leptin and resting energy expenditure during a refeeding period after the subjects were severely energy restricted for 4 wk. In contrast, Rosenbaum et al. (42) found no correlation between changes in serum leptin and changes in energy expenditure in humans. The disparity in results may be explained by the fact that Wisse et al. measured the leptin at a time when dynamic changes in energy balance were occurring, whereas Rosenbaum et al. measured leptin during periods when energy intake was static. These findings suggest that leptin does not cause elevations in energy expenditure that would prevent the development of diet-induced obesity.
The correlation between leptin and adipocyte size found in this study has been demonstrated in several other studies involving both animals and humans (11, 17). After 2 wk on the HFS diet, without a significant change in adipocyte cell size, the HFS animals already exhibited hyperleptinemia compared with the LFCC-fed animals. The plasma leptin rose throughout the 20 mo in the HFS group and paralleled the increase in adipocyte cell size. Ahren et al. (1) demonstrated a similar effect of a high-fat diet on the relationship between leptin and fat mass in mice maintained on the diet for 12 mo. In other studies, however, treating animals with leptin resulted in a paradoxical loss of adipose tissue stores (6). In some humans, this effect of leptin on the adipose tissue stores has also been demonstrated (20). Thus amelioration of diet-induced metabolic abnormalities (e.g., insulin resistance, hyperglycemia, hypertriglyceridemia, obesity) by leptin may require administration of exogenous leptin as shown by Buettner et al. (8), who used a recombinant adenovirus containing the leptin cDNA.
Exposure of Fischer 344 rats to a HFS diet has previously been shown to cause insulin resistance and hyperinsulinemia after 2 wk (5). The hyperleptinemia observed at 2 wk before any change in fat cell size in the HFS rats is possibly the result of a stimulatory effect of insulin on ob gene expression. It is known that insulin is an adipogenic hormone (24), and insulin and glucose together regulate leptin production and secretion (35). In the rodent model, hyperinsulinemia is associated with overexpression of ob mRNA, and insulin has been reported to directly elevate leptin mRNA in rat adipocytes (13, 43).
Normally, obesity is thought to be simply the result of an energy intake-energy expenditure imbalance. We measured the metabolizable energy intake of the HFS and LFCC diets rather than gross energy intake, because diets high in fiber and unrefined carbohydrates have a lower metabolizable energy content (50), and consequently the availability of nutrients from the feed ingredients is lower in the LFCC diet. This is due to the increase in energy loss mainly through the feces. Nevertheless, the metabolizable energy intakes in both groups were nearly equal during the 20-mo study. However, the HFS group had a higher FE, which may have contributed to the weight gain, because the digestibility of the diet affects FE and weight gain (10). The fact that the difference in energy intake only could explain 2.5% of the weight gain supports this contention. We suggest that the higher FE is a potential explanation for the greater weight gain noted in rodent models despite equivalent energy intakes or even lower gross caloric intake in animals ingesting high-sucrose diets, high-fat diets (37), or both (40). The higher residue diet ingested by the LFCC would require increased mechanical work by the gastrointestinal tract, increasing gastrointestinal energy expenditure.
It is probable that other factors are playing a role in the weight gain. First, protein and carbohydrate possess a higher thermic effect compared with fat (47), which may contribute to energy expenditure. Second, the conversion of excess dietary fat into body fat is a more efficient process than the conversion of protein or carbohydrate into body fat (15), and normally carbohydrate and protein balances are tightly regulated, whereas fat balance is not (46). Third, differences in energy expenditure may be present, because there are inherent limitations in the extrapolations of activity and body temperature measured only over 5 days. Namely, although not statistically different, the cumulative difference over 20 mo in activity and body temperature may have contributed to some of the difference in body weight. At some point during the course of the study, it is possible that energy lost as heat may change to affect energy expenditure. Additionally, because proton leaks constitute a considerable part of an organisms' metabolic rate, differences in the activities of uncoupling proteins may contribute to the differences noted between the diet groups (14). Although probably not an initiating response, as fat accumulates in the animal, it provides an insulating effect, such that it would lessen heat dissipation, facilitating the maintenance of body temperature. Additionally, the rise in insulin may have played a role in the obesity as documented by weight gain and adipocyte hypertrophy in the HFS group. Our laboratory has previously reported that hyperinsulinemia in the HFS diet group was associated with reductions in skeletal muscle and elevations in adipose tissue lipoprotein lipase activity, lipoprotein lipase protein, and very-low-density lipoprotein-receptor protein expression (39). This would enhance fat storage, contributing to obesity.
We acknowledge that there are inherent limitations to our study. First, because we measured the weight of the food present in bowls for each group, we cannot rule out the possibility that there may be differences in the rate of spillage between the groups; however, this was observed to be minimal. Second, the activity was determined by using monitors that can only detect large movements that occurred as the animals moved to different portions of the cages, which would not account for animal fidgeting. Third, we measured the leptin during fasting because metabolic parameters are normally measured during fasting conditions to eliminate any potential confounding acute influences of the last meal, which may result in an inaccurate reflection of the long-term chronic response. In doing so, the leptin concentration during nonfasted periods of the day, which may not have differed between the groups, was not accounted for. However, there is evidence in obese individuals that feeding does not reduce leptin levels. For example, Guerci et al. (18) demonstrated that leptin is not acutely affected with an oral fat load in normal or obese individuals. The obese patients had significantly higher leptin than the controls during fasting and the subsequent 8-h period after the meal was consumed. Furthermore, Imbeault et al. (22) fed a high-fat meal to lean and obese men, and leptin decreased slightly but remained fourfold higher than lean controls in the 8-h period after the meal. Thus we suggest that leptin would be elevated in our HFS rats throughout the day as well as in the fasted state, as we observed.
Overall, the present study has documented that long-term consumption of the HFS diet increases fat cell size and plasma leptin concentration. The increase in leptin noted in the HFS diet-fed animals was associated with elevated plasma insulin levels and was highly correlated with fat cell hypertrophy, but it was unrelated to energy intake or markers of energy expenditure in this model.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by National Institutes of Health (NIH) Grant AG-05792 and by a grant from the L-B Research/Education Foundation. C. Roberts is supported by a National Research Scholarship Award postdoctoral fellowship (NIH F32 HL-68406-01).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: R. J. Barnard, Physiological Science, UCLA, P.O. Box 951606, Los Angeles, CA 90095-1606 (E-mail: jbarnard{at}physci.ucla.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
May 31, 2002;10.1152/japplphysiol.00224.2002
Received 15 March 2002; accepted in final form 25 May 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ahren, B,
Mansson S,
Gingerich RL,
and
Havel PJ.
Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting.
Am J Physiol Regul Integr Comp Physiol
273:
R113-R120,
1997
2.
Ashwell, M,
Priest P,
Bondoux M,
Sowter C,
and
McPherson CK.
Human fat cell sizing
a quick, simple method.
J Lipid Res
17:
190-192,
1976[Abstract].
3.
Astrup, A,
Buemann B,
Western P,
Toubro S,
Raben A,
and
Christensen NJ.
Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study.
Am J Clin Nutr
59:
350-355,
1994
4.
Barnard, RJ,
Berger JJ,
Ong JM,
and
Kern PA.
Adipocyte and muscle changes in response to diet leading to obesity.
Diabetes Res Clin Pract
33:
213-228,
1998.
5.
Barnard, RJ,
Roberts CK,
Varon SM,
and
Berger JJ.
Diet-induced insulin resistance precedes other aspects of the metabolic syndrome.
J Appl Physiol
84:
1311-1315,
1998
6.
Barzilai, N,
Wang J,
Massilon D,
Vuguin P,
Hawkins M,
and
Rossetti L.
Leptin selectively decreases visceral adiposity and enhances insulin action.
J Clin Invest
100:
3105-3110,
1997[Web of Science][Medline].
7.
Boden, G,
Chen X,
Mozzoli M,
and
Ryan I.
Effect of fasting on serum leptin in normal human subjects.
J Clin Endocrinol Metab
81:
3419-3423,
1996[Abstract].
8.
Buettner, R,
Newgard CB,
Rhodes CJ,
and
O'Doherty RM.
Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia.
Am J Physiol Endocrinol Metab
278:
E563-E569,
2000
9.
Campfield, LA,
Smith FJ,
and
Burn P.
Strategies and potential molecular targets for obesity treatment.
Science
280:
1383-1387,
1998
10.
Collins, AR,
Howard-Taylor TR,
Hsueh WA,
and
Meehan WP.
Interactions of troglitizone and diet on growth and energy metabolism in LDLr
/
mice (Abstract).
Diabetes
47:
A457,
1999.
11.
Considine, RV,
Sinha MK,
Heiman ML,
Kriauciunas A,
Stephens TW,
Nyce MR,
Ohannesian JP,
Marco CC,
McKee LJ,
Bauer TL,
Serum immunoreactive-leptin concentrations in normal-weight and obese humans.
N Engl J Med
334:
292-295,
1996
12.
Coppack, SW,
Pinkney JH,
and
Mohamed-Ali V.
Leptin production in human adipose tissue.
Proc Nutr Soc
57:
461-470,
1998[Web of Science][Medline].
13.
Cusin, I,
Sainsbury A,
Doyle P,
Rohner-Jeanrenaud F,
and
Jeanrenaud B.
The ob gene and insulin. A relationship leading to clues to the understanding of obesity.
Diabetes
44:
1467-1470,
1995[Abstract].
14.
Dalgaard, LT,
and
Pedersen O.
Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes.
Diabetologia
44:
946-965,
2001[Web of Science][Medline].
15.
Flatt, JP.
The biochemistry of energy expenditure.
In: Recent Advances in Obesity Research II, edited by Bray G.. London: Libbey, 1980, p. 211-218.
16.
Flegal, KM,
Carroll MD,
Kuczmarski RJ,
and
Johnson CL.
Overweight and obesity in the United States: prevalence and trends, 1960-1994.
Int J Obes Relat Metab Disord
22:
39-47,
1998[Web of Science][Medline].
17.
Frederich, RC,
Hamann A,
Anderson S,
Lollmann B,
Lowell BB,
and
Flier JS.
Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action.
Nat Med
1:
1311-1314,
1995[Web of Science][Medline].
18.
Guerci, B,
Hadjadj S,
Quilliot D,
Ziegler O,
and
Drouin P.
No acute response of leptin to an oral fat load in obese patients and during circadian rhythm in healthy controls.
Eur J Endocrinol
143:
649-655,
2000[Abstract].
19.
Havel, PJ.
Mechanisms regulating leptin production: implications for control of energy balance.
Am J Clin Nutr
70:
305-306,
1999
20.
Heymsfield, SB,
Greenberg AS,
Fujioka K,
Dixon RM,
Kushner R,
Hunt T,
Lubina JA,
Patane J,
Self B,
Hunt P,
and
McCamish M.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
JAMA
282:
1568-1575,
1999
21.
Houseknecht, KL,
Mantzoros CS,
Kuliawat R,
Hadro E,
Flier JS,
and
Kahn BB.
Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity.
Diabetes
45:
1638-1643,
1996[Abstract].
22.
Imbeault, P,
Doucet E,
Mauriege P,
St-Pierre S,
Couillard C,
Almeras N,
Despres JP,
and
Tremblay A.
Difference in leptin response to a high-fat meal between lean and obese men.
Clin Sci (Lond)
101:
359-365,
2001[Medline].
23.
Kasim, SE,
Martino S,
Kim PN,
Khilnani S,
Boomer A,
Depper J,
Reading BA,
and
Heilbrun LK.
Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women.
Am J Clin Nutr
57:
146-153,
1993
24.
Kazdova, L,
and
Vrana A.
Insulin and adipose tissue cellularity.
Horm Metab Res
2:
117-118,
1970[Medline].
25.
Kolaczynski, JW,
Considine RV,
Ohannesian J,
Marco C,
Opentanova I,
Nyce MR,
Myint M,
and
Caro JF.
Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves.
Diabetes
45:
1511-1515,
1996[Abstract].
26.
Kolaczynski, JW,
Ohannesian JP,
Considine RV,
Marco CC,
and
Caro JF.
Response of leptin to short-term and prolonged overfeeding in humans.
J Clin Endocrinol Metab
81:
4162-4165,
1996
27.
Lemonnier, D.
Effect of age, sex, and sites on the cellularity of the adipose tissue in mice and rats rendered obese by a high-fat diet.
J Clin Invest
51:
2907-2915,
1972[Web of Science][Medline].
28.
Li, H,
Matheny M,
Nicolson M,
Tumer N,
and
Scarpace PJ.
Leptin gene expression increases with age independent of increasing adiposity in rats.
Diabetes
46:
2035-2039,
1997[Abstract].
29.
Lin, L,
Martin R,
Schaffhauser AO,
and
York DA.
Acute changes in the response to peripheral leptin with alteration in the diet composition.
Am J Physiol Regul Integr Comp Physiol
280:
R504-R509,
2001
30.
Lin, X,
Chavez MR,
Bruch RC,
Kilroy GE,
Simmons LA,
Lin L,
Braymer HD,
Bray GA,
and
York DA.
The effects of a high fat diet on leptin mRNA, serum leptin and the response to leptin are not altered in a rat strain susceptible to high fat diet-induced obesity.
J Nutr
128:
1606-1613,
1998
31.
Maffei, M,
Halaas J,
Ravussin E,
Pratley RE,
Lee GH,
Zhang Y,
Fei H,
Kim S,
Lallone R,
Ranganathan S,
Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects.
Nat Med
1:
1155-1161,
1995[Web of Science][Medline].
32.
Miller, WC,
Lindeman AK,
Wallace J,
and
Niederpruem M.
Diet composition, energy intake, and exercise in relation to body fat in men and women.
Am J Clin Nutr
52:
426-430,
1990
33.
Mokdad, AH,
Serdula MK,
Dietz WH,
Bowman BA,
Marks JS,
and
Koplan JP.
The spread of the obesity epidemic in the United States, 1991-1998.
JAMA
282:
1519-1522,
1999
34.
Montague, CT,
Farooqi IS,
Whitehead JP,
Soos MA,
Rau H,
Wareham NJ,
Sewter CP,
Digby JE,
Mohammed SN,
Hurst JA,
Cheetham CH,
Earley AR,
Barnett AH,
Prins JB,
and
O'Rahilly S.
Congenital leptin deficiency is associated with severe early-onset obesity in humans.
Nature
387:
903-908,
1997[Medline].
35.
Mueller, WM,
Gregoire FM,
Stanhope KL,
Mobbs CV,
Mizuno TM,
Warden CH,
Stern JS,
and
Havel PJ.
Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes.
Endocrinology
139:
551-558,
1998
36.
Oscai, LB,
Brown MM,
and
Miller WC.
Effect of dietary fat on food intake, growth and body composition in rats.
Growth
48:
415-424,
1984[Web of Science][Medline].
37.
Oscai, LB,
Miller WC,
and
Arnall DA.
Effects of dietary sugar and of dietary fat on food intake and body fat content in rats.
Growth
51:
64-73,
1987[Web of Science][Medline].
38.
Pelleymounter, MA,
Cullen MJ,
Baker MB,
Hecht R,
Winters D,
Boone T,
and
Collins F.
Effects of the obese gene product on body weight regulation in ob/ob mice.
Science
269:
540-543,
1995
39.
Roberts, CK,
Barnard RJ,
Liang KH,
and
Vaziri ND.
Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia.
Atherosclerosis
161:
133-141,
2002[Web of Science][Medline].
40.
Roberts, CK,
Vaziri ND,
Liang KH,
and
Barnard RJ.
Reversibility of chronic experimental syndrome X by diet.
Hypertension
37:
1323-1328,
2001
41.
Rosenbaum, M,
and
Leibel RL.
The role of leptin in human physiology.
N Engl J Med
341:
913-915,
1999
42.
Rosenbaum, M,
Nicolson M,
Hirsch J,
Murphy E,
Chu F,
and
Leibel RL.
Effects of weight change on plasma leptin concentrations and energy expenditure.
J Clin Endocrinol Metab
82:
3647-3654,
1997
43.
Saladin, R,
De Vos P,
Guerre-Millo M,
Leturque A,
Girard J,
Staels B,
and
Auwerx J.
Transient increase in obese gene expression after food intake or insulin administration.
Nature
377:
527-529,
1995[Medline].
44.
Sheehan, D,
and
Hrapchak B.
Theory and Practice of Histotechnology. St. Louis, MO: Mosby, 1980.
45.
Steinberg, GR,
and
Dyck DJ.
Development of leptin resistance in rat soleus muscle in response to high-fat diets.
Am J Physiol Endocrinol Metab
279:
E1374-E1382,
2000
46.
Swinburn B and Ravussin E. Energy balance or fat balance?
Am J Clin Nutr 57: 766S-770S; discussion
770S-771S, 1993.
47.
Tappy, L.
Thermic effect of food and sympathetic nervous system activity in humans.
Reprod Nutr Dev
36:
391-397,
1996[Web of Science][Medline].
48.
Van Heek, M,
Compton DS,
France CF,
Tedesco RP,
Fawzi AB,
Graziano MP,
Sybertz EJ,
Strader CD,
and
Davis HR, Jr.
Diet-induced obese mice develop peripheral, but not central, resistance to leptin.
J Clin Invest
99:
385-390,
1997[Web of Science][Medline].
49.
Vecchione, C,
Maffei A,
Colella S,
Aretini A,
Poulet R,
Frati G,
Gentile MT,
Fratta L,
Trimarco V,
Trimarco B,
and
Lembo G.
Leptin effect on endothelial nitric oxide is mediated through akt-endothelial nitric oxide synthase phosphorylation pathway.
Diabetes
51:
168-173,
2002
50.
Wisker, E,
and
Feldheim W.
Metabolizable energy of diets low or high in dietary fiber from fruits and vegetables when consumed by humans.
J Nutr
120:
1331-1337,
1990
51.
Wisse, BE,
Campfield LA,
Marliss EB,
Morais JA,
Tenenbaum R,
and
Gougeon R.
Effect of prolonged moderate and severe energy restriction and refeeding on plasma leptin concentrations in obese women.
Am J Clin Nutr
70:
321-330,
1999
52.
Yirmiya, R,
Tio DL,
and
Taylor AN.
Effects of fetal alcohol exposure on fever, sickness behavior, and pituitary-adrenal activation induced by interleukin-1 beta in young adult rats.
Brain Behav Immun
10:
205-220,
1996[Web of Science][Medline].
This article has been cited by other articles:
![]() |
C. K. Roberts Inactivity and fat cell hyperplasia: fat chance? J Appl Physiol, April 1, 2007; 102(4): 1308 - 1309. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |